Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -43.94% is 24% below its 5-year average of -35.39%, near the low end of its 5-year range (-57.12%–-1.15%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.39% above its 12-month average of -47.45%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -43.94%.
RETURN ON EQUITY (ROE)
-43.94%
RETURN ON EQUITY (ROE) AVG TTM
-47.45%
RETURN ON EQUITY (ROE) AVG 3Y
-47.72%
RETURN ON EQUITY (ROE) AVG 5Y
-35.39%
RETURN ON EQUITY (ROE) AVG 10Y
-38.31%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+7.39%
CURRENT VS 3Y AVG
+7.92%
CURRENT VS 5Y AVG
-24.17%
CURRENT VS 10Y AVG
-14.71%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-38.57%
median of 561 covered companies
CURRENT VS SECTOR MEDIAN
-13.93%
vs the sector median at left
Novocure Ltd
Market Cap
$1.84B
Return on Equity (ROE)
-43.94%
TTM Avg
-47.45%
3Y Avg
-47.72%
5Y Avg
-35.39%
Market Cap
$1.84B
Return on Equity (ROE)
4.88%
TTM Avg
4.47%
3Y Avg
6.79%
5Y Avg
5.89%
Market Cap
$1.82B
Return on Equity (ROE)
15.62%
TTM Avg
13.87%
3Y Avg
11.38%
5Y Avg
11.40%
Market Cap
$1.87B
Return on Equity (ROE)
-49.19%
TTM Avg
-59.18%
3Y Avg
-54.84%
5Y Avg
-44.72%
Market Cap
$1.89B
Return on Equity (ROE)
-40.09%
TTM Avg
4.56%
3Y Avg
-13.84%
5Y Avg
-2.18%
Market Cap
$1.90B
Return on Equity (ROE)
N/A
TTM Avg
-157.29%
3Y Avg
-33.70%
5Y Avg
49.06%
Market Cap
$1.89B
Return on Equity (ROE)
12.01%
TTM Avg
-4.52%
3Y Avg
-16.89%
5Y Avg
-11.36%
Market Cap
$1.78B
Return on Equity (ROE)
N/A
TTM Avg
36.48%
3Y Avg
36.48%
5Y Avg
36.48%
Market Cap
$1.89B
Return on Equity (ROE)
-8.14%
TTM Avg
-6.28%
3Y Avg
-6.47%
5Y Avg
-2.03%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novocure Ltd (NVCR) | $1.84B | -43.94% | -47.45% | -47.72% | -35.39% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 4.88% | 4.47% | 6.79% | 5.89% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 15.62% | 13.87% | 11.38% | 11.40% |
| Absci Corporation (ABSI)vs › | $1.87B | -49.19% | -59.18% | -54.84% | -44.72% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | -40.09% | 4.56% | -13.84% | -2.18% |
| Novavax, Inc. (NVAX)vs › | $1.90B | N/A | -157.29% | -33.70% | 49.06% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 12.01% | -4.52% | -16.89% | -11.36% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | N/A | 36.48% | 36.48% | 36.48% |
| Azenta, Inc. (AZTA)vs › | $1.89B | -8.14% | -6.28% | -6.47% | -2.03% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.74B | -54.96% | -60.50% | -51.30% | -42.73% |
ROE
-43.9%
ROA
-18.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -43.94% |
| 2026-03-31 | -52.32% |
| 2025-12-31 | -40.01% |
| 2025-09-30 | -52.05% |
| 2025-06-30 | -48.92% |
| 2025-03-31 | -45.36% |
| 2024-12-31 | -46.82% |
| 2024-09-30 | -41.52% |
| 2024-06-30 | -46.63% |
| 2024-03-31 | -53.64% |
| 2023-12-31 | -57.12% |
| 2023-09-30 | -50.11% |
| 2023-06-30 | -41.94% |
| 2023-03-31 | -32.62% |
| 2022-12-31 | -20.97% |
| 2022-09-30 | -18.34% |
| 2022-06-30 | -15.45% |
| 2022-03-31 | -13.51% |
| 2021-12-31 | -14.21% |
| 2021-09-30 | -6.53% |
| 2021-06-30 | -1.15% |
| 2021-03-31 | 3.15% |
| 2020-12-31 | 4.16% |
| 2020-09-30 | 6.24% |
| 2020-06-30 | 4.40% |
| 2020-03-31 | 3.67% |
| 2019-12-31 | -3.32% |
| 2019-09-30 | -14.25% |
| 2019-06-30 | -25.64% |
| 2019-03-31 | -43.50% |
| 2018-12-31 | -56.62% |
| 2018-09-30 | -51.22% |
| 2018-06-30 | -52.35% |
| 2018-03-31 | -60.63% |
| 2017-12-31 | -54.30% |
| 2017-09-30 | -62.46% |
| 2017-06-30 | -80.83% |
| 2017-03-31 | -88.79% |
| 2016-12-31 | -92.62% |
| 2016-09-30 | -90.12% |
| 2016-06-30 | -72.33% |
| 2016-03-31 | -56.14% |
| 2015-12-31 | -44.49% |
| 2015-09-30 | -83.79% |
| 2015-06-30 | -65.05% |
| 2015-03-31 | -112.33% |
| 2014-12-31 | -82.43% |
